Nuo Therapeutics Inc (AURX)
0.75
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Nuo Therapeutics Total Liabilities (Quarterly): 0.8387M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.8387M |
September 30, 2023 | 0.8732M |
June 30, 2023 | 0.9144M |
March 31, 2023 | 0.8828M |
December 31, 2022 | 0.856M |
September 30, 2022 | 0.7142M |
June 30, 2022 | 0.7611M |
March 31, 2022 | 0.531M |
December 31, 2021 | 0.6731M |
September 30, 2021 | 0.6725M |
December 31, 2020 | 0.6689M |
December 31, 2019 | 0.6665M |
September 30, 2019 | 1.323M |
June 30, 2019 | 1.346M |
March 31, 2019 | 1.173M |
December 31, 2018 | 1.058M |
September 30, 2018 | 1.342M |
June 30, 2018 | 1.096M |
March 31, 2018 | 1.157M |
December 31, 2017 | 0.9412M |
September 30, 2017 | 1.744M |
June 30, 2017 | 1.930M |
March 31, 2017 | 1.612M |
December 31, 2016 | 1.571M |
September 30, 2016 | 1.854M |
Date | Value |
---|---|
June 30, 2016 | 2.789M |
March 31, 2016 | 47.79M |
December 31, 2015 | 43.13M |
September 30, 2015 | 13.12M |
June 30, 2015 | 26.74M |
March 31, 2015 | 32.33M |
December 31, 2014 | 40.26M |
September 30, 2014 | 47.49M |
June 30, 2014 | 49.22M |
March 31, 2014 | 24.71M |
December 31, 2013 | 19.44M |
September 30, 2013 | 15.97M |
June 30, 2013 | 10.93M |
March 31, 2013 | 10.48M |
December 31, 2012 | 6.328M |
September 30, 2012 | 7.347M |
June 30, 2012 | 7.524M |
March 31, 2012 | 39.04M |
December 31, 2011 | 6.797M |
September 30, 2011 | 8.492M |
June 30, 2011 | 5.454M |
March 31, 2011 | 7.260M |
December 31, 2010 | 8.980M |
September 30, 2010 | 7.782M |
June 30, 2010 | 5.934M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.531M
Minimum
Mar 2022
1.346M
Maximum
Jun 2019
0.8373M
Average
0.7999M
Median
Total Liabilities (Quarterly) Benchmarks
AIM ImmunoTech Inc | 9.147M |
Perspective Therapeutics Inc | 22.71M |
Protalix BioTherapeutics Inc | 60.04M |
Electromed Inc | 6.357M |
Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.878M |
Shareholders Equity (Quarterly) | 1.039M |
Current Ratio | 2.318 |